Tickerplace logo

Tickerplace

Bristol-Myers Squibb Company logo

BMYBristol-Myers Squibb Company

BMY Stock Price, Valuation & Chart | Bristol-Myers Squibb Company

Compare
$60.570+1.29 (+2.18%)

At close · 15 Oct 2026, 08:00 pm

Sector: HealthcareIndustry: Drug Manufacturers - General
OverviewFinancialsDividendsRatios

BMY Historical price chart

BMY Key Stats

Market Capitalization123.73B
PE Ratio10.21
EPS5.93
Trading Volume13.47M
Today's High/Low62.25/60.39
Dividend Yield4.16
52 Week High/Low68.64/42.52
Shares Outstanding2.04B
BMY Financial Statement
BMY Analyst ratings
BMY Analysis & performance metrics

BMY Company profile

Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology,…

BMY Management team

Management
Christopher S. Boerner Ph.D.CEO
Chief Executive Officer & Chairman
Charles E. Triano
SVice President & Head of Investor Relations
Cari Gallman
Executive Vice President, General Counsel & Chief Policy Officer
Ahn Amanda Poole
Executive Vice President & Chief People Officer
Joseph J. Eiden Jr.
Head of Medical Affairs
Kimberly M. Jablonski
Chief Compliance & Ethics Officer
Adam Lenkowsky
Executive Vice President & Chief Commercialization Officer
Greg Meyers
Executive Vice President and Chief Digital & Technology Officer
Total 8 executives

BMY Frequently asked questions

What is Bristol-Myers Squibb Company (BMY) Stock Price?

Current stock price of Bristol-Myers Squibb Company (BMY) stock is $60.570. The stock price is +2.18% higher in the session. The intraday range can be seen from this page. Volume of Bristol-Myers Squibb Company (BMY) stock is 13.47M.

Last updated at 15 Oct 2026, 08:00 pm.

Why is the Bristol-Myers Squibb Company (BMY) stock price going up or down today?

The stock price of Bristol-Myers Squibb Company (BMY) can change with earnings, company news, and overall market sentiment. Bristol-Myers Squibb Company operates in the Healthcare / Drug Manufacturers - General market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Bristol-Myers Squibb Company stock expensive at its current price?

Whether Bristol-Myers Squibb Company looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for BMY on this page is 10.21. EPS on this page is 5.93. Compare those figures with peers and growth expectations before deciding if the current Bristol-Myers Squibb Company price is justified.

How has the stock price of Bristol-Myers Squibb Company (BMY) performed historically?

Historical performance for Bristol-Myers Squibb Company (BMY) is shown on the price chart on this page. Review multi-period moves alongside volume to see how BMY reacted to past earnings and market events.

Should I buy Bristol-Myers Squibb Company (BMY) stock, at this price?

Buying Bristol-Myers Squibb Company (BMY) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.